Lawrence E. Crane

Array ( [id] => 7511397 [patent_doc_number] => 20110257107 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-20 [patent_title] => 'Compounds for Delivering Amino Acids or Peptides with Antioxidant Activity into Mitochondria' [patent_app_type] => utility [patent_app_number] => 13/169604 [patent_app_country] => US [patent_app_date] => 2011-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 11291 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0257/20110257107.pdf [firstpage_image] =>[orig_patent_app_number] => 13169604 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7511410 [patent_doc_number] => 20110257120 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-20 [patent_title] => 'BETA-L-2\'-DEOXY-NUCLEOSIDES FOR THE TREATMENT OF HEPATITIS B' [patent_app_type] => utility [patent_app_number] => 13/170118 [patent_app_country] => US [patent_app_date] => 2011-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 18278 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0257/20110257120.pdf [firstpage_image] =>[orig_patent_app_number] => 13170118 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8406446 [patent_doc_number] => 20120238513 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-20 [patent_title] => 'METHOD FOR INHIBITING ACTIVATION OF MACROPHAGES' [patent_app_type] => utility [patent_app_number] => 13/161369 [patent_app_country] => US [patent_app_date] => 2011-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 7935 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13161369 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8431153 [patent_doc_number] => 20120253028 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-04 [patent_title] => 'METHOD FOR DEBLOCKING OF LABELED OLIGONUCLEOTIDES' [patent_app_type] => utility [patent_app_number] => 13/152907 [patent_app_country] => US [patent_app_date] => 2011-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 2631 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13152907 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8527962 [patent_doc_number] => 08304532 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-11-06 [patent_title] => 'Method for preparing oligonucleotides' [patent_app_type] => utility [patent_app_number] => 13/115845 [patent_app_country] => US [patent_app_date] => 2011-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26479 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13115845 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8853082 [patent_doc_number] => 20130142757 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-06-06 [patent_title] => 'PYRAZOLE DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 13/698548 [patent_app_country] => US [patent_app_date] => 2011-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22289 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13698548 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10567632 [patent_doc_number] => 09290791 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-03-22 [patent_title] => 'Reagents and methods for sirtuin capture' [patent_app_type] => utility [patent_app_number] => 13/698561 [patent_app_country] => US [patent_app_date] => 2011-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 14 [patent_no_of_words] => 15246 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13698561 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7561758 [patent_doc_number] => 20110275591 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-10 [patent_title] => 'COCKTAIL FOR MODULATION OF ALZHEIMER\'S DISEASE' [patent_app_type] => utility [patent_app_number] => 13/104588 [patent_app_country] => US [patent_app_date] => 2011-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 17105 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20110275591.pdf [firstpage_image] =>[orig_patent_app_number] => 13104588 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10122521 [patent_doc_number] => 09156873 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-10-13 [patent_title] => 'Modified 5′ diphosphate nucleosides and oligomeric compounds prepared therefrom' [patent_app_type] => utility [patent_app_number] => 13/642804 [patent_app_country] => US [patent_app_date] => 2011-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40284 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13642804 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10090220 [patent_doc_number] => 09127033 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-09-08 [patent_title] => '5′ modified nucleosides and oligomeric compounds prepared therefrom' [patent_app_type] => utility [patent_app_number] => 13/642809 [patent_app_country] => US [patent_app_date] => 2011-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 45782 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13642809 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9068704 [patent_doc_number] => 20130260460 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-10-03 [patent_title] => 'CONFORMATIONALLY RESTRICTED DINUCLEOTIDE MONOMERS AND OLIGONUCLEOTIDES' [patent_app_type] => utility [patent_app_number] => 13/643062 [patent_app_country] => US [patent_app_date] => 2011-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 63777 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13643062 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8398625 [patent_doc_number] => 08268988 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-09-18 [patent_title] => 'Process for preparing an A2A-adenosine receptor agonist and its polymorphs' [patent_app_type] => utility [patent_app_number] => 13/092812 [patent_app_country] => US [patent_app_date] => 2011-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8165 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13092812 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8756161 [patent_doc_number] => 20130090466 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-04-11 [patent_title] => 'CRYSTALLIZATION PROCESS OF CYCLIC ADENOSINE 3\',5\'-MONOPHOSPHATE' [patent_app_type] => utility [patent_app_number] => 13/702039 [patent_app_country] => US [patent_app_date] => 2011-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3677 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13702039 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8612698 [patent_doc_number] => 20130018010 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-17 [patent_title] => 'POLYMERIC CONJUGATES OF ADENINE NUCLEOSIDE ANALOGS' [patent_app_type] => utility [patent_app_number] => 13/637297 [patent_app_country] => US [patent_app_date] => 2011-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 14595 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13637297 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8457836 [patent_doc_number] => 08293502 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-10-23 [patent_title] => 'Emulsion PCR and amplicon capture' [patent_app_type] => utility [patent_app_number] => 13/087278 [patent_app_country] => US [patent_app_date] => 2011-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 13365 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13087278 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6177502 [patent_doc_number] => 20110178038 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-21 [patent_title] => 'Indole Antiviral Compositions And Methods' [patent_app_type] => utility [patent_app_number] => 13/077538 [patent_app_country] => US [patent_app_date] => 2011-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 29734 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0178/20110178038.pdf [firstpage_image] =>[orig_patent_app_number] => 13077538 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8792676 [patent_doc_number] => 20130109645 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-02 [patent_title] => 'ADENOSINE RECEPTOR AGONISTS FOR THE TREATMENT AND PREVENTION OF VASCULAR OR JOINT CAPSULE CALCIFICATION DISORDERS' [patent_app_type] => utility [patent_app_number] => 13/582035 [patent_app_country] => US [patent_app_date] => 2011-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 19506 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13582035 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8896726 [patent_doc_number] => 08476247 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-07-02 [patent_title] => 'Method of reducing intraocular pressure in humans' [patent_app_type] => utility [patent_app_number] => 13/072349 [patent_app_country] => US [patent_app_date] => 2011-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9942 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13072349 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8063651 [patent_doc_number] => 20110245194 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-06 [patent_title] => 'ADENOSINE COMPOUNDS AND THEIR USE THEREOF' [patent_app_type] => utility [patent_app_number] => 13/071993 [patent_app_country] => US [patent_app_date] => 2011-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 11200 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0245/20110245194.pdf [firstpage_image] =>[orig_patent_app_number] => 13071993 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8063653 [patent_doc_number] => 20110245193 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-06 [patent_title] => 'COMBINATION COMPOSITIONS FOR REDUCING INTRAOCULAR PRESSURE' [patent_app_type] => utility [patent_app_number] => 13/051633 [patent_app_country] => US [patent_app_date] => 2011-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9149 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0245/20110245193.pdf [firstpage_image] =>[orig_patent_app_number] => 13051633 [rel_patent_id] =>[rel_patent_doc_number] =>)